SB
PPH icon

Suntrust Banks’s VanEck Pharmaceutical ETF PPH Stock Holding History

Suntrust Banks’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-11,916
Closed -$696K – 1310
2017
Q2 		$696K Buy
11,916
+2,843
+31% +$161K ﹤0.01% 751
2017
Q1 		$530K Buy
9,073
+3,387
+60% +$184K ﹤0.01% 822
2016
Q4 		$331K Buy
5,686
+2,189
+63% +$117K ﹤0.01% 1214
2016
Q3 		$204K Buy
+3,497
New +$210K ﹤0.01% 1415
2016
Q1 		– Sell
-25,924
Closed -$1.69M – 1506
2015
Q4 		$1.69M Buy
25,924
+2,091
+9% +$135K 0.01% 494
2015
Q3 		$1.5M Buy
23,833
+2,445
+11% +$172K 0.01% 494
2015
Q2 		$1.51M Buy
21,388
+4,797
+29% +$345K 0.01% 491
2015
Q1 		$1.17M Buy
16,591
+1,200
+8% +$81.4K 0.01% 563
2014
Q4 		$989K Buy
15,391
+4,098
+36% +$261K 0.01% 607
2014
Q3 		$717K Sell
11,293
-676
-6% -$41.9K 0.01% 815
2014
Q2 		$741K Sell
11,969
-1,638
-12% -$97.4K 0.01% 832
2014
Q1 		$793K Buy
13,607
+3,149
+30% +$178K ﹤0.01% 1089
2013
Q4 		$555K Buy
10,458
+1,385
+15% +$70.1K ﹤0.01% 1213
2013
Q3 		$433K Buy
9,073
+3,529
+64% +$167K ﹤0.01% 1298
2013
Q2 		$251K Buy
+5,544
New +$256K ﹤0.01% 1489

Other funds holding PPH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Suntrust Banks's PPH Position: Q3 2017 in Review

Suntrust Banks sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2017, closing a stake of 11,916 shares — an estimated $696K sold.

Suntrust Banks first reported a position in PPH in Q2 2013 and held it in 15 quarters. The position peaked at $1.69M in Q4 2015. 48 funds tracked by Wall St. Rank hold PPH as of Q3 2017.

  • Suntrust Banks reported no remaining VanEck Pharmaceutical ETF position as of Q3 2017 after selling out during the quarter.
  • Suntrust Banks sold 11,916 VanEck Pharmaceutical ETF shares in Q3 2017, an estimated $696K.
  • Suntrust Banks first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and held it in 15 quarters.
  • Suntrust Banks's VanEck Pharmaceutical ETF position peaked at $1.69M in Q4 2015.
  • 48 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2017.

Based on Suntrust Banks's 13F filing for Q3 2017, filed 14 Nov 2017.